Cold News and Research

RSS

What do we know about the SARS-CoV-2 vaccines so far?

A new study surveys what we know so far about SARS-CoV-2 vaccine candidates from advanced clinical trials.

27 Jan 2021

Why even presidential pressure might not get more vaccine to market faster

Americans are dying of covid-19 by the thousands, but efforts to ramp up production of potentially lifesaving vaccines are hitting a brick wall.

26 Jan 2021

Microglial cells contribute to the negative mood experienced during neurological diseases

Special immune cells found in the brain, microglia, play a key role in the processes that make you feel uneasy and depressed in correlation with inflammation.

26 Jan 2021

Promising nanobodies against COVID-19 produced by llamas

News-Medical speaks to Dr. David Brody about his latest research that involved discovering nanobodies produced by llamas that could help combat coronavirus.

25 Jan 2021

EKF opens larger facility to increase production of key component for COVID-19 testing regime

EKF’s new facilities in Llandough, Cardiff, for the manufacture of PrimeStore® MTM viral transport media, enabling pathogenic samples to be collected and transported safely and easily in compliance with UN3373 packaging regulations.

From EKF Diagnostics 22 Jan 2021

Study reveals specific neuronal circuits underlying environment-based value learning

How valuable are earmuffs? The answer to this simple question can depend. What brand are they? Are they good quality? What is the weather like? Given the choice between earmuffs and suntan lotion, most people would choose to have the earmuffs on a cold winter day and the lotion on a sunny day at the beach.

22 Jan 2021

New sensory neuron model enables easy generation of cells to fast-track pain research

Scientists have for the first time established a sensory neuron model able to mass-reproduce two key sensory neuron types involved in pain sensation, enabling the easy generation of large numbers of the cells to fast-track chronic pain research.

21 Jan 2021

Yurts, igloos and pop-up domes: How safe is ‘outside’ restaurant dining this winter?

With the arrival of winter and the U.S. coronavirus outbreak in full swing, the restaurant industry — looking at losses of $235 billion in 2020 — is clinging to techniques for sustaining outdoor dining even through the cold and vagaries of a U.S. winter.

21 Jan 2021

New mobile app to reduce food waste

Today, data.org announced the eight global winners of the $10 million Inclusive Growth and Recovery Challenge, which aims to address major societal challenges through computer and data science.

20 Jan 2021

Bacteria responsible for seafood-related stomach upsets can go dormant and "wake up"

Scientists have discovered how bacteria commonly responsible for seafood-related stomach upsets can go dormant and then "wake up".

20 Jan 2021

Immune systems of COVID-19 patients may rely on antibodies from earlier coronaviruses

The results of a study led by Northern Arizona University and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest the immune systems of people infected with COVID-19 may rely on antibodies created during infections from earlier coronaviruses to help fight the disease.

20 Jan 2021

Supply chain delays affect planned stockpile of Ebola vaccines

Supply chain delays must be addressed to speed up creation of a stockpile of vaccines against deadly Ebola disease, researchers say.

19 Jan 2021

Lower CD4 T cell reactivity to seasonal coronaviruses found in healthcare workers with COVID-19

A new study by US-based researchers describes the results of a study on the immune response among healthcare workers, in particular, their T cell responses predating the pandemic.

19 Jan 2021

Scientists set research priorities for COVID-19 vaccines

More than 2,800 scientists from 130 countries gathered on Friday (January 15) in a virtual forum hosted by the World Health Organization (WHO) to identify knowledge gaps and set research priorities for vaccines against SARS-CoV-2, the virus that causes COVID-19.

19 Jan 2021

International health organizations establish global Ebola vaccine stockpile

The four leading international health and humanitarian organizations announced today the establishment of a global Ebola vaccine stockpile to ensure outbreak response.

18 Jan 2021

Treating post-infectious smell loss in COVID-19 patients

News-Medical catches up with Professor Carl Philpott about the latest findings regarding COVID-19 and smell loss.

18 Jan 2021

Researchers produce first African lion in-vitro embryos after vitrification of immature oocytes

A team of scientists from the Leibniz Institute for Zoo and Wildlife Research (Leibniz-IZW) inGermany, Givskud Zoo - Zootopia in Denmark and the University of Milan in Italy succeeded in producing the very first African lionin-vitroembryos after the vitrification of immature oocytes.

18 Jan 2021

A high-temperature tolerant SARS-CoV-2 derived immunogen as a potential vaccine candidate

There have been significant efforts worldwide to combat COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). One prominent strategy has been to develop vaccines against the virus. Numerous vaccine candidates are under development, and a handful have now been approved for use by several countries.

17 Jan 2021

Jellagen launches JellaGel™, the first Collagen Type 0 Hydrogel taking on the market leading Extracellular Matrix

Jellagen® Limited, a biotechnology company manufacturing high-value Collagen Type 0 derived from jellyfish, announce the launch of their JellaGel™ Hydrogel.

From Jellagen 15 Jan 2021

Targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers

Researchers at Baylor College of Medicine have discovered how therapeutics targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers (TNBC) to trigger tumor cell death and signal the body's immune response.

15 Jan 2021

Cold News and Research

What do we know about the SARS-CoV-2 vaccines so far?

Why even presidential pressure might not get more vaccine to market faster

Microglial cells contribute to the negative mood experienced during neurological diseases

Promising nanobodies against COVID-19 produced by llamas

EKF opens larger facility to increase production of key component for COVID-19 testing regime

Study reveals specific neuronal circuits underlying environment-based value learning

New sensory neuron model enables easy generation of cells to fast-track pain research

Yurts, igloos and pop-up domes: How safe is ‘outside’ restaurant dining this winter?

New mobile app to reduce food waste

Bacteria responsible for seafood-related stomach upsets can go dormant and "wake up"

Immune systems of COVID-19 patients may rely on antibodies from earlier coronaviruses

Supply chain delays affect planned stockpile of Ebola vaccines

Lower CD4 T cell reactivity to seasonal coronaviruses found in healthcare workers with COVID-19

Scientists set research priorities for COVID-19 vaccines

International health organizations establish global Ebola vaccine stockpile

Treating post-infectious smell loss in COVID-19 patients

Researchers produce first African lion in-vitro embryos after vitrification of immature oocytes

A high-temperature tolerant SARS-CoV-2 derived immunogen as a potential vaccine candidate

Jellagen launches JellaGel™, the first Collagen Type 0 Hydrogel taking on the market leading Extracellular Matrix

Targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News